Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
about
Development of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusA review of treatment modalities for Middle East Respiratory Syndrome.Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.Current progress in innovative engineered antibodies.Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus.Infectious diseases: Cattle engineered to produce human antibodies against coronavirus.An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus.Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape.MERS-CoV: Understanding the Latest Human Coronavirus Threat.A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
P2860
Q26700054-24AABF39-38F4-413B-9A6E-01EA2253604FQ30248209-726D431F-BD57-447F-9597-D198B90D5338Q30356651-0F909ADD-E201-4CD4-AA25-2A908AC6C7A8Q37188934-E7D7AA91-93A8-4404-B767-8E3507C83221Q39034541-7834741F-B1FD-4190-8DED-4B40BD99078FQ40040079-03555CE7-D469-4A41-9F20-BF27DD544A3FQ40077818-E8AF4EAE-BAC9-4D74-9EC0-275399D76AD6Q40216590-2DE9ECA7-032A-45AF-BF4A-31FD3586F2DDQ40317741-56C5C781-CD33-4720-8C86-8EB2B25666B9Q40558082-9460E169-AEFA-425C-9E0C-90CED6836126Q40733724-3B9EB3A5-8390-4EA1-8470-651305168695Q42330835-DDB19BF0-1BA3-4A22-B370-BBF461AB8B69Q42351533-778CC8F1-6368-40F4-9F16-D38BBCC11D93Q43280688-2ED4CD8F-37E2-4381-936C-1B43CC4F88B7Q47132991-49E95400-FF0C-4525-A8BD-7523DD73EB56Q47548101-17741BAE-50CB-4F50-8935-5AC34DDF63B7Q47607374-F10FC791-5D5C-49D3-95CB-F59005327421Q47656792-16004C5F-3E09-4DE4-AB87-960EA1D67F91Q51149122-449C8751-AEC1-43C1-A1C9-E68A16A67C27Q53701486-6512B03E-1D0A-4999-B196-173A6D297AA1Q58710181-B69172FB-2FA5-4B9C-B7CB-C72F94B6C858
P2860
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Human polyclonal immunoglobuli ...... nes inhibits MERS-CoV in vivo.
@en
type
label
Human polyclonal immunoglobuli ...... nes inhibits MERS-CoV in vivo.
@en
altLabel
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
@en
prefLabel
Human polyclonal immunoglobuli ...... nes inhibits MERS-CoV in vivo.
@en
P2093
P2860
P50
P1476
Human polyclonal immunoglobuli ...... nes inhibits MERS-CoV in vivo.
@en
P2093
Britini L Ork
David Flyer
Elena N Postnikova
Gabriel Defang
Gale Smith
Gregory Glenn
Hiroaki Matsushita
Jin-An Jiao
Jincun Zhao
P2860
P304
P356
10.1126/SCITRANSLMED.AAF1061
P407
P577
2016-02-01T00:00:00Z